● Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Condition: Refractory Rheumatoid Arthritis (RA) · Idiopathic Inflammatory Myopathies (IIMs) · Systemic Sclerosis (SSc) · Sponsor: Artiva Biotherapeutics, Inc.

PhasePhase 2

Planned participants90

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

A Basket Trial of Refractory Rheumatoid Arthritis (RA), Sjögren's Disease (SjD), Idiopathic Inflammatory Myopathies (IIMs) and Systemic Sclerosis (SSc) subjects to evaluate the safety and efficacy of AlloNK, a non-genetically modified allogeneic NK cell, in combination with rituximab.

This description comes directly from the study's public registry record.

Talk to the study team

Chanel Mansfield Director, Clinical Operations, MPH · 1 858 223 7001 · clinicaltrials@artivabio.com

Always discuss trial participation with your own doctor first.

Locations (52)

Artiva Investigational Site Tuscaloosa	Tuscaloosa, Alabama, United States	Recruiting
Artiva Investigational Site Phoenix	Phoenix, Arizona, United States	Recruiting
Artiva Investigational Site Tucson	Tucson, Arizona, United States	Recruiting
Artiva Investigational Site Chula Vista	Chula Vista, California, United States	Recruiting
Artiva Investigational Site Covina	Covina, California, United States	Recruiting
Artiva Investigational Site Los Alamitos	Los Alamitos, California, United States	Recruiting
Artiva Investigational Site Los Angeles	Los Angeles, California, United States	Recruiting
Artiva Investigational Site Santa Ana	Santa Ana, California, United States	Recruiting
Artiva Investigational Site Tustin	Tustin, California, United States	Recruiting
Artiva Investigational Site Jupiter	Jupiter, Florida, United States	Recruiting
Artiva Investigational Site Miami	Miami, Florida, United States	Recruiting
Artiva Investigational Site Plantation	Plantation, Florida, United States	Recruiting

+ 40 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06991114